Market Overview

Ocular Therapeutix (NASDAQ: OCUL)

5.19 -0.11 (-2.08%)

Earnings

QuarterPriorEstimateActualSurprise
Q1 2020
Pre-Market
EPS:
REV:
-0.45
492K



Q4 2019
After-Hours
EPS:
REV:
-0.42
504K



Q3 2019
After-Hours
EPS:
REV:
-0.38
498K



Q2 2019
After-Hours
EPS:
REV:
-0.37
648K



Q1 2019
Pre-Market
EPS:
REV:
-0.40
340K
-0.42
430K
-0.45
492K
-7.14%
14.42%
Q4 2018
After-Hours
EPS:
REV:
-0.44
487K
-0.38
480K
-0.42
504K
10.53%
5%
Q3 2018
After-Hours
EPS:
REV:
-0.54
523K
-0.38
470K
-0.38
498K

5.96%
Q2 2018
After-Hours
EPS:
REV:
-0.64
438K
-0.38
380K
-0.37
648K
-2.63%
70.53%
Q1 2018
After-Hours
EPS:
REV:
-0.58
475K
-0.38
450K
-0.40
340K
5.26%
-24.44%
Q4 2017
Pre-Market
EPS:
REV:
-0.52
511K
-0.52
520K
-0.44
487K
-15.38%
-6.35%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!